Gyncentrum Sp. z o.o. — Clinical Trial Site

84 Registered trials

63 Currently recruiting

Organisation

Gyncentrum Sp. z o.o.

Location

Katowice, Poland

Identifier

ORG-100044129

Address

Ul. Zelazna 1, 40-851, Poland

Departments

-
#45001: NZOZ Holsamed- Oddzial Libero
#5703: Dermatology
2702: NZOZ Holsamed - Oddział Libero
505: NZOZ Holsamed - Oddzial Libero
Allergology
Badania Kliniczne
Clinical Trial
Dermatologia
Dermatology
Gyncentrum
Gyncentrum - Szpital
GynCentrum Sp. z o. o., NZOZ Holsamed - Oddział Liberoul.Kościuszki 229, 40-600 Katowice,Poland
Gyncentrum Sp. z o.o.
Gynecology
Gynocentrum
N/A
NA
NZOZ Gyncentrum
NZOZ GynCentrum - Oddzial Bielsko-Biala
NZOZ GynCentrum - Oddzial Czestochowa
NZOZ GynCentrum - Oddzial Krakow
NZOZ GynCentrum - Oddzial Poznan
NZOZ GynCentrum - Oddzial Warszawa
NZOZ GynCentrum - Oddzial Wroclaw
NZOZ GynCentrum - Oddział Bielsko-Biała
NZOZ Gyncentrum - Oddział Kraków
NZOZ GynCentrum - Oddział Warszawa
NZOZ GynCentrum – Oddział Warszawa
NZOZ Gyncentrum Oddział Warszawa
NZOZ Gyncentrum-Oddzial Warszawa
NZOZ Holsamed - Oddzial Libero
NZOZ Holsamed - Oddział Libero
NZOZ Holsamed - Odział Libero
NZOZ Holsamed – Oddział Libero
NZOZ Holsamed – Odział Libero
NZOZ Holsamed- Oddział Libero
NZOZ Holsamed-Oddzial Libero
NZOZ Holsamed-Oddział Libero
Oddzial Warszawa
Oddział Warszawa
POL05432: Dermatology
Psychiatry
TBC

Clinical trials at this site (84)

Search interface

"A Clinical Study to Evaluate the Effectiveness of Beltavac® with polymerized extract of grass pollen mixture in allergic rhinoconjunctivit… Not authorised

2023-510033-28-00 allergic rhinoconjunctivitis caused due to exposure to 4
"A Clinical Study to Evaluate the Effectiveness of Beltavac® with polymerized extract of grass pollen mixture in allergic rhinoconjunctivit… Not authorised

2025-520581-22-00 Allergic rhinoconjunctivitis caused due to exposure to 4
A study to find an efficacious and safe dose of CHF10067 (zampilimab) in participants with idiopathic pulmonary fibrosis Pending

2024-514246-37-00 Idiopathic pulmonary fibrosis (IPF) 4
Dose-ranging study evaluating the efficacy and safety of EVO756 in adults with Chronic Spontaneous Urticaria. Pending

2024-518786-10-01 Moderate to Severe Chronic Spontaneous Urticaria 4
A Study to Evaluate the Efficacy and Safety of IMG-007 in Adult Participants with Moderate-to-Severe Atopic Dermatitis (ADAPTIVE) Pending

2024-520117-50-00 Atopic Dermatitis 4
A Study of Vepugratinib (LY3866288) in Participants with Cancer in the Urinary Tract ( FORAGER-2 ) Pending

2025-522855-25-00 Carcinoma, Transitional Cell 5
Long-term safety and efficacy evaluation of lunsekimig (SAR443765) in adult participants with moderate-to-severe asthma. Recruiting

2025-522896-27-00 Asthma 4 2026-05-11
A Study of how the Medicine Called "Etrasimod" Works in Children With the gut Disease Called Ulcerative Colitis Recruiting

2025-523100-77-00 Ulcerative Colitis 4 2026-04-23
Dose-finding study of LAD603 in adults with alopecia areata Recruiting

2025-523342-27-00 Alopecia areata 4 2026-04-10
A Phase III, randomized, controlled study of furazidin for bacterial vaginosis. Recruiting

2024-515332-80-00 Bacterial vaginosis 5 2026-02-23
Zasocitinib in Nonsegmental Vitiligo Recruiting

2025-522309-40-00 Non-segmental vitiligo 4 2026-02-11
Long-term study to assess the safety and tolerability of adjunctive NBI-1065845 in adults with Major Depressive Disorder (MDD) Recruiting

2024-519423-24-00 Major Depressive Disorder 5 2025-10-07
A Study to Evaluate the Long-term Safety and Effectiveness of APG777 in Subjects with Atopic Dermatitis Recruiting

2024-519795-11-00 Atopic Dermatitis 4 2025-10-06
Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obe… Recruiting

2024-520209-38-00 Obesity or Overweight 5 2025-09-19
A Randomized, Parallel-Group, Double-Blind, Placebo-Controlled, Monotherapy Study of the Efficacy, Safety, and Tolerability of SPT-300 in Ad… Recruiting

2025-521240-37-00 Major Depressive Disorder (MDD), with or without Anxiou 4 2025-09-11
Selective Treatment of Oral Povorcitinib Long-Term Rollover Study (STOP-LTR) Recruiting

2024-520107-12-00 Hidradenitis Suppurativa // Prurigo Nodularis // Vitili 5 2025-09-03
A dose ranging study to investigate efficacy and safety of subcutaneous TOUR006 compared with placebo in participants 18 to 80 years of age … Recruiting

2024-514801-69-00 Thyroid Eye Disease 4 2025-04-02
Selective Treatment of Oral Povorcitinib in Prurigo Nodularis Study 1 (STOP-PN1) Recruiting

2024-511879-16-00 Prurigo Nodularis 5 2024-12-12
Study of GS-1427 in Participants With Moderately to Severely Active UC Recruiting

2023-508304-38-00 Ulcerative Colitis (UC) 4 2024-09-10
A randomised, double-blind, double-dummy, multicentre, phase III, non inferiority trial of an oral mesalazine formulation in patients with a… Recruiting

2023-509606-30-00 Ulcerative colitis 5 2024-07-24
Non-controlled, open-label study to evaluate tolerability, safety, and efficacy of MOB015B solution for external use in the treatment of mil… Recruiting

2024-513214-34-00 Distal Subungual Onychomycosis 4 2023-10-18
A Study to Evaluate Etrasimod Treatment in Adolescents With Ulcerative Colitis Recruiting

2022-500345-25-00 Moderately to severely active ulcerative colitis 4 2023-01-16
AMAZE 4: A research study investigating how well the medicine NNC0487-0111 helps people with excess body weight and obstructive sleep apnoea… Recruiting

2024-520443-16-00 Overweight or obesity, and obstructive sleep apnoea tre 5 2026-05-04
AMAZE 3: A research study investigating how well the medicine NNC0487-0111 helps people with excess body weight and obstructive sleep apnoea… Recruiting

2024-520442-36-00 Overweight or obesity, and obstructive sleep apnoea not 5 2026-04-30